MedPage Today37m
How the FDA Opens the Door to Risky Chemicals in America's Food Supply
In 1958, Congress mandated that, before additives could be used in foods, manufacturers had to prove they were safe and get ...
Male enhancement capsules recalled for undeclared ingredients, FDA announces
One Source Nutrition, Inc. is voluntarily recalling all of its Vitality male enhancement capsules nationwide after an FDA ...
Trump’s pick to lead FDA tells senators he’d look into food, abortion pill, vaccine advisers
President Donald Trump’s pick to lead the US Food and Drug Administration told senators in a tense confirmation hearing ...
BioSpace13h
FDA Action Alert: GSK, Alnylam, Sanofi and More
One of the most highly anticipated FDA decisions this month is for Alnylam Pharmaceuticals, which is seeking to expand the ...
Dexcom receives FDA warning letter for two U.S. manufacturing facilities
Medical device maker Dexcom said it has received a warning letter from the U.S. Food and Drug Administration following ...
Fierce Pharma3h
Neurotech nabs FDA approval to treat rare eye disorder with cell therapy implant Encelto
With a U.S. green light for its encapsulated cell therapy technology in the bag, privately held biotech Neurotech ...
US FDA expands use of ARS Pharma's allergic reaction nasal spray in 15-30 kg patients (March 5)
Shares of the company were up 5.2% in extended trading. The spray, sold under the brand name neffy, will be dosed at 1 ...
FDA nominee pitches AI application review
In particular, AI could assist FDA staff to review drug and device applications, he told senators on the Health, Education, ...
DexCom Gets FDA Warning Letter After Inspections of Facilities
DexCom received a warning letter from the Food and Drug Administration following inspections of its San Diego and Mesa, Ariz.
FDA nominee sidesteps questions on abortion pill, agency layoffs and other issues
Dr. Marty Makary is largely sidestepping Senate questions about his plans to lead the Food and Drug Administration.
RFK Jr. has it wrong — the FDA approves too few drugs
However, fresh evidence from the HHS’ watchdog shows the problem is not a pushover FDA. If anything, the problem is a ...
FDA's Proposed Nicotine Rule: Communicating Harm Reduction In Times Of Policy Change
For communications leaders across industries, this initiative underscores the critical importance of crafting clear messaging ...